<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">33833754</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>06</Month>
        <Day>25</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>06</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">1664-3224</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>12</Volume>
            <PubDate>
              <Year>2021</Year>
            </PubDate>
          </JournalIssue>
          <Title>Frontiers in immunology</Title>
          <ISOAbbreviation>Front Immunol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Intestinal Dysbiosis and Autoimmune Pancreatitis.</ArticleTitle>
        <Pagination>
          <StartPage>621532</StartPage>
          <MedlinePgn>621532</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">621532</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2021.621532</ELocationID>
        <Abstract>
          <AbstractText>Autoimmune pancreatitis (AIP) is a chronic fibro-inflammatory disorder of the pancreas. Recent clinicopathological analysis revealed that most cases of AIP are pancreatic manifestations of systemic IgG4-related disease (IgG4-RD), a newly established disease characterized by enhanced IgG4 antibody responses and the involvement of multiple organs. Although the immuno-pathogenesis of AIP and IgG4-RD has been poorly defined, we recently showed that activation of plasmacytoid dendritic cells (pDCs) with the ability to produce large amounts of IFN-α and IL-33 mediates chronic fibro-inflammatory responses in experimental and human AIP. Moreover, M2 macrophages producing a large amount of IL-33 play pathogenic roles in the development of human IgG4-RD. Interestingly, recent studies including ours provide evidence that compositional alterations of gut microbiota are associated with the development of human AIP and IgG4-RD. In addition, intestinal dysbiosis plays pathological roles in the development of chronic pancreatic inflammation as dysbiosis mediates the activation of pDCs producing IFN-α and IL-33, thereby causing experimental AIP. In this Mini Review, we focus on compositional alterations of gut microbiota in AIP and IgG4-RD to clarify the mechanisms by which intestinal dysbiosis contributes to the development of these disorders.</AbstractText>
          <CopyrightInformation>Copyright © 2021 Yoshikawa, Watanabe, Kamata, Hara, Minaga and Kudo.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Yoshikawa</LastName>
            <ForeName>Tomoe</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology and Hepatology, Kindai University, Faculty of Medicine, Ohno-Higashi, Osaka-Sayama, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Watanabe</LastName>
            <ForeName>Tomohiro</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology and Hepatology, Kindai University, Faculty of Medicine, Ohno-Higashi, Osaka-Sayama, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kamata</LastName>
            <ForeName>Ken</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology and Hepatology, Kindai University, Faculty of Medicine, Ohno-Higashi, Osaka-Sayama, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hara</LastName>
            <ForeName>Akane</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology and Hepatology, Kindai University, Faculty of Medicine, Ohno-Higashi, Osaka-Sayama, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Minaga</LastName>
            <ForeName>Kosuke</ForeName>
            <Initials>K</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology and Hepatology, Kindai University, Faculty of Medicine, Ohno-Higashi, Osaka-Sayama, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kudo</LastName>
            <ForeName>Masatoshi</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology and Hepatology, Kindai University, Faculty of Medicine, Ohno-Higashi, Osaka-Sayama, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>03</Month>
          <Day>23</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Front Immunol</MedlineTA>
        <NlmUniqueID>101560960</NlmUniqueID>
        <ISSNLinking>1664-3224</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D016898">Interferon-alpha</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000067596">Interleukin-33</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000081012" MajorTopicYN="N">Autoimmune Pancreatitis</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003713" MajorTopicYN="N">Dendritic Cells</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D064806" MajorTopicYN="N">Dysbiosis</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000069196" MajorTopicYN="N">Gastrointestinal Microbiome</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000077733" MajorTopicYN="N">Immunoglobulin G4-Related Disease</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016898" MajorTopicYN="N">Interferon-alpha</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000067596" MajorTopicYN="N">Interleukin-33</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D023421" MajorTopicYN="N">Models, Animal</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">IgG4-related disease</Keyword>
        <Keyword MajorTopicYN="Y">autoimmune pancreatitis</Keyword>
        <Keyword MajorTopicYN="Y">dysbiosis</Keyword>
        <Keyword MajorTopicYN="Y">intestinal microbiota</Keyword>
        <Keyword MajorTopicYN="Y">plasmacytoid dendritic cells</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>10</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>9</Day>
          <Hour>6</Hour>
          <Minute>26</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>10</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>6</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33833754</ArticleId>
        <ArticleId IdType="pmc">PMC8021793</ArticleId>
        <ArticleId IdType="doi">10.3389/fimmu.2021.621532</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
Levy M, Kolodziejczyk AA, Thaiss CA, Elinav E. Dysbiosis and the immune system. Nat Rev Immunol (2017) 17:219–32.  10.1038/nri.2017.7
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nri.2017.7</ArticleId>
            <ArticleId IdType="pubmed">28260787</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Skelly AN, Sato Y, Kearney S, Honda K. Mining the microbiota for microbial and metabolite-based immunotherapies. Nat Rev Immunol (2019) 19:305–23.  10.1038/s41577-019-0144-5
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41577-019-0144-5</ArticleId>
            <ArticleId IdType="pubmed">30858494</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lynch SV, Pedersen O. The Human Intestinal Microbiome in Health and Disease. N Engl J Med (2016) 375:2369–79.  10.1056/NEJMra1600266
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMra1600266</ArticleId>
            <ArticleId IdType="pubmed">27974040</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Honjo H, Watanabe T, Arai Y, Kamata K, Minaga K, Komeda Y, et al. . ATG16L1 negatively regulates RICK/RIP2-mediated innate immune responses. Int Immunol (2021) 33:91–105.  10.1093/intimm/dxaa062
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/intimm/dxaa062</ArticleId>
            <ArticleId IdType="pubmed">32909611</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Watanabe T, Minaga K, Kamata K, Sakurai T, Komeda Y, Nagai T, et al. . RICK/RIP2 is a NOD2-independent nodal point of gut inflammation. Int Immunol (2019) 31:669–83.  10.1093/intimm/dxz045
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/intimm/dxz045</ArticleId>
            <ArticleId IdType="pmc">PMC6939834</ArticleId>
            <ArticleId IdType="pubmed">31132297</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Adolph TE, Mayr L, Grabherr F, Schwarzler J, Tilg H. Pancreas-Microbiota Cross Talk in Health and Disease. Annu Rev Nutr (2019) 39:249–66.  10.1146/annurev-nutr-082018-124306
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev-nutr-082018-124306</ArticleId>
            <ArticleId IdType="pubmed">31433743</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Akshintala VS, Talukdar R, Singh VK, Goggins M. The Gut Microbiome in Pancreatic Disease. Clin Gastroenterol Hepatol (2019) 17:290–5.  10.1016/j.cgh.2018.08.045
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cgh.2018.08.045</ArticleId>
            <ArticleId IdType="pmc">PMC6314887</ArticleId>
            <ArticleId IdType="pubmed">30144522</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Thomas RM, Jobin C. Microbiota in pancreatic health and disease: the next frontier in microbiome research. Nat Rev Gastroenterol Hepatol (2020) 17:53–64.  10.1038/s41575-019-0242-7
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41575-019-0242-7</ArticleId>
            <ArticleId IdType="pubmed">31811279</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Watanabe T, Kudo M, Strober W. Immunopathogenesis of pancreatitis. Mucosal Immunol (2017) 10:283–98.  10.1038/mi.2016.101
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/mi.2016.101</ArticleId>
            <ArticleId IdType="pubmed">27848953</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Tsuji Y, Watanabe T, Kudo M, Arai H, Strober W, Chiba T. Sensing of Commensal Organisms by the Intracellular Sensor NOD1 Mediates Experimental Pancreatitis. Immunity (2012) 37:326–38.  10.1016/j.immuni.2012.05.024
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.immuni.2012.05.024</ArticleId>
            <ArticleId IdType="pmc">PMC3523885</ArticleId>
            <ArticleId IdType="pubmed">22902233</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kamisawa T, Chari ST, Lerch MM, Kim MH, Gress TM, Shimosegawa T. Recent advances in autoimmune pancreatitis: type 1 and type 2. Gut (2013) 62:1373–80.  10.1136/gutjnl-2012-304224
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/gutjnl-2012-304224</ArticleId>
            <ArticleId IdType="pubmed">23749606</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Watanabe T, Minaga K, Kamata K, Kudo M, Strober W. Mechanistic Insights into Autoimmune Pancreatitis and IgG4-Related Disease. Trends Immunol (2018) 39:874–89.  10.1016/j.it.2018.09.005
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.it.2018.09.005</ArticleId>
            <ArticleId IdType="pubmed">30401468</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kamisawa T, Zen Y, Pillai S, Stone JH. IgG4-related disease. Lancet (2015) 385:1460–71.  10.1016/S0140-6736(14)60720-0
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(14)60720-0</ArticleId>
            <ArticleId IdType="pubmed">25481618</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med (2012) 366:539–51.  10.1056/NEJMra1104650
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMra1104650</ArticleId>
            <ArticleId IdType="pubmed">22316447</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Shiokawa M, Kodama Y, Sekiguchi K, Kuwada T, Tomono T, Kuriyama K, et al. . Laminin 511 is a target antigen in autoimmune pancreatitis. Sci Trans Med (2018) 10:eaaq0997.  10.1126/scitranslmed.aaq0997
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/scitranslmed.aaq0997</ArticleId>
            <ArticleId IdType="pubmed">30089633</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Perugino CA, AlSalem SB, Mattoo H, Della-Torre E, Mahajan V, Ganesh G, et al. . Identification of galectin-3 as an autoantigen in patients with IgG4-related disease. J Allergy Clin Immunol (2019) 143:736–45.e6.  10.1016/j.jaci.2018.05.011
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jaci.2018.05.011</ArticleId>
            <ArticleId IdType="pmc">PMC6265117</ArticleId>
            <ArticleId IdType="pubmed">29852256</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hubers LM, Vos H, Schuurman AR, Erken R, Oude Elferink RP, Burgering B, et al. . Annexin A11 is targeted by IgG4 and IgG1 autoantibodies in IgG4-related disease. Gut (2018) 67:728–35.  10.1136/gutjnl-2017-314548
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/gutjnl-2017-314548</ArticleId>
            <ArticleId IdType="pubmed">28765476</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Shiokawa M, Kodama Y, Kuriyama K, Yoshimura K, Tomono T, Morita T, et al. . Pathogenicity of IgG in patients with IgG4-related disease. Gut (2016) 65:1322–32.  10.1136/gutjnl-2015-310336
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/gutjnl-2015-310336</ArticleId>
            <ArticleId IdType="pubmed">26964842</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Aalberse RC, Stapel SO, Schuurman J, Rispens T. Immunoglobulin G4: an odd antibody. Clin Exp Allergy (2009) 39:469–77.  10.1111/j.1365-2222.2009.03207.x
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2222.2009.03207.x</ArticleId>
            <ArticleId IdType="pubmed">19222496</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Bach JF. The hygiene hypothesis in autoimmunity: the role of pathogens and commensals. Nat Rev Immunol (2018) 18:105–20.  10.1038/nri.2017.111
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nri.2017.111</ArticleId>
            <ArticleId IdType="pubmed">29034905</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kamata K, Watanabe T, Minaga K, Hara A, Yoshikawa T, Okamoto A, et al. . Intestinal dysbiosis mediates experimental autoimmune pancreatitis via activation of plasmacytoid dendritic cells. Int Immunol (2019) 31:795–809.  10.1093/intimm/dxz050
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/intimm/dxz050</ArticleId>
            <ArticleId IdType="pubmed">31287532</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kamata K, Watanabe T, Minaga K, Hara A, Sekai I, Otsuka Y, et al. . Gut microbiome alterations in type 1 autoimmune pancreatitis after induction of remission by prednisolone. Clin Exp Immunol (2020) 202:308–20. 10.1111/cei.13509
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/cei.13509</ArticleId>
            <ArticleId IdType="pmc">PMC7670154</ArticleId>
            <ArticleId IdType="pubmed">32880930</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol (2005) 17:1–14.  10.1093/intimm/dxh186
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/intimm/dxh186</ArticleId>
            <ArticleId IdType="pubmed">15585605</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Strober W, Murray PJ, Kitani A, Watanabe T. Signalling pathways and molecular interactions of NOD1 and NOD2. Nat Rev Immunol (2006) 6:9–20.  10.1038/nri1747
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nri1747</ArticleId>
            <ArticleId IdType="pubmed">16493424</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ishiguro N, Moriyama M, Furusho K, Furukawa S, Shibata T, Murakami Y, et al. . Activated M2 Macrophages Contribute to the Pathogenesis of IgG4-Related Disease via Toll-like Receptor 7/Interleukin-33 Signaling. Arthritis Rheumatol (2020) 72:166–78.  10.1002/art.41052
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/art.41052</ArticleId>
            <ArticleId IdType="pmc">PMC6972995</ArticleId>
            <ArticleId IdType="pubmed">31339007</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Fukui Y, Uchida K, Sakaguchi Y, Fukui T, Nishio A, Shikata N, et al. . Possible involvement of Toll-like receptor 7 in the development of type 1 autoimmune pancreatitis. J Gastroenterol (2015) 50:435–44.  10.1007/s00535-014-0977-4
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00535-014-0977-4</ArticleId>
            <ArticleId IdType="pubmed">25005350</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Furukawa S, Moriyama M, Miyake K, Nakashima H, Tanaka A, Maehara T, et al. . Interleukin-33 produced by M2 macrophages and other immune cells contributes to Th2 immune reaction of IgG4-related disease. Sci Rep (2017) 7:42413.  10.1038/srep42413
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/srep42413</ArticleId>
            <ArticleId IdType="pmc">PMC5304322</ArticleId>
            <ArticleId IdType="pubmed">28205524</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Arai Y, Yamashita K, Kuriyama K, Shiokawa M, Kodama Y, Sakurai T, et al. . Plasmacytoid Dendritic Cell Activation and IFN-alpha Production Are Prominent Features of Murine Autoimmune Pancreatitis and Human IgG4-Related Autoimmune Pancreatitis. J Immunol (2015) 195:3033–44.  10.4049/jimmunol.1500971
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.1500971</ArticleId>
            <ArticleId IdType="pubmed">26297761</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Watanabe T, Yamashita K, Arai Y, Minaga K, Kamata K, Nagai T, et al. . Chronic Fibro-Inflammatory Responses in Autoimmune Pancreatitis Depend on IFN-alpha and IL-33 Produced by Plasmacytoid Dendritic Cells. J Immunol (2017) 198:3886–96.  10.4049/jimmunol.1700060
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.1700060</ArticleId>
            <ArticleId IdType="pubmed">28373582</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kamata K, Watanabe T, Minaga K, Strober W, Kudo M. Autoimmune Pancreatitis Mouse Model. Curr Protoc Immunol (2018) 120:15 31 1–15 31 8.  10.1002/cpim.41
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cpim.41</ArticleId>
            <ArticleId IdType="pubmed">0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Swiecki M, Colonna M. The multifaceted biology of plasmacytoid dendritic cells. Nat Rev Immunol (2015) 15:471–85.  10.1038/nri3865
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nri3865</ArticleId>
            <ArticleId IdType="pmc">PMC4808588</ArticleId>
            <ArticleId IdType="pubmed">26160613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ganguly D. Do Type I Interferons Link Systemic Autoimmunities and Metabolic Syndrome in a Pathogenetic Continuum? Trends Immunol (2018) 39:28–43.  10.1016/j.it.2017.07.001
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.it.2017.07.001</ArticleId>
            <ArticleId IdType="pubmed">28826817</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Watanabe T, Sadakane Y, Yagama N, Sakurai T, Ezoe H, Kudo M, et al. . Nucleotide-binding oligomerization domain 1 acts in concert with the cholecystokinin receptor agonist, cerulein, to induce IL-33-dependent chronic pancreatitis. Mucosal Immunol (2016) 9:1234–49.  10.1038/mi.2015.144
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/mi.2015.144</ArticleId>
            <ArticleId IdType="pubmed">26813347</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Minaga K, Watanabe T, Arai Y, Shiokawa M, Hara A, Yoshikawa T, et al. . Activation of interferon regulatory factor 7 in plasmacytoid dendritic cells promotes experimental autoimmune pancreatitis. J Gastroenterol (2020) 55:565–76.  10.1007/s00535-020-01662-2
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00535-020-01662-2</ArticleId>
            <ArticleId IdType="pubmed">31960143</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Minaga K, Watanabe T, Hara A, Kamata K, Omoto S, Nakai A, et al. . Identification of serum IFN-alpha and IL-33 as novel biomarkers for type 1 autoimmune pancreatitis and IgG4-related disease. Sci Rep (2020) 10:14879.  10.1038/s41598-020-71848-4
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-020-71848-4</ArticleId>
            <ArticleId IdType="pmc">PMC7495433</ArticleId>
            <ArticleId IdType="pubmed">32938972</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hamada S, Masamune A, Nabeshima T, Shimosegawa T. Differences in Gut Microbiota Profiles between Autoimmune Pancreatitis and Chronic Pancreatitis. Tohoku J Exp Med (2018) 244:113–7.  10.1620/tjem.244.113
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1620/tjem.244.113</ArticleId>
            <ArticleId IdType="pubmed">29434076</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Yamaki K, Ohta M, Nakashima I, Noda A, Asai J, Kato N. Microbial adjuvant and autoimmunity. IV. Production of lesions in the exocrine pancreas of mice by repeated injection of syngeneic pancreatic extract together with the capsular polysaccharide of Klebsiella pneumoniae. Microbiol Immunol (1980) 24:945–56.  10.1111/j.1348-0421.1980.tb02900.x
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1348-0421.1980.tb02900.x</ArticleId>
            <ArticleId IdType="pubmed">7007828</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Contractor N, Louten J, Kim L, Biron CA, Kelsall BL. Cutting edge: Peyer’s patch plasmacytoid dendritic cells (pDCs) produce low levels of type I interferons: possible role for IL-10, TGFbeta, and prostaglandin E2 in conditioning a unique mucosal pDC phenotype. J Immunol (2007) 179:2690–4.  10.4049/jimmunol.179.5.2690
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.179.5.2690</ArticleId>
            <ArticleId IdType="pubmed">17709480</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Haruta I, Yanagisawa N, Kawamura S, Furukawa T, Shimizu K, Kato H, et al. . A mouse model of autoimmune pancreatitis with salivary gland involvement triggered by innate immunity via persistent exposure to avirulent bacteria. Lab Invest (2010) 90:1757–69.  10.1038/labinvest.2010.153
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/labinvest.2010.153</ArticleId>
            <ArticleId IdType="pubmed">20733561</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Cayrol C, Girard JP. IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy. Curr Opin Immunol (2014) 31C:31–7.  10.1016/j.coi.2014.09.004
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.coi.2014.09.004</ArticleId>
            <ArticleId IdType="pubmed">25278425</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Conrad C, Gregorio J, Wang YH, Ito T, Meller S, Hanabuchi S, et al. . Plasmacytoid dendritic cells promote immunosuppression in ovarian cancer via ICOS costimulation of Foxp3(+) T-regulatory cells. Cancer Res (2012) 72:5240–9.  10.1158/0008-5472.CAN-12-2271
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-12-2271</ArticleId>
            <ArticleId IdType="pmc">PMC3652570</ArticleId>
            <ArticleId IdType="pubmed">22850422</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Watanabe T, Yamashita K, Fujikawa S, Sakurai T, Kudo M, Shiokawa M, et al. . Activation of Toll-like Receptors and NOD-like Receptors Is Involved in Enhanced IgG4 Responses in Autoimmune Pancreatitis. Arthritis Rheumatism (2012) 64:914–24. 10.1002/art.33386
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/art.33386</ArticleId>
            <ArticleId IdType="pubmed">21971969</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Garrett WS. Immune recognition of microbial metabolites. Nat Rev Immunol (2020) 20:91–2.  10.1038/s41577-019-0252-2
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41577-019-0252-2</ArticleId>
            <ArticleId IdType="pubmed">31768024</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ji J, Shu D, Zheng M, Wang J, Luo C, Wang Y, et al. . Microbial metabolite butyrate facilitates M2 macrophage polarization and function. Sci Rep (2016) 6:24838.  10.1038/srep24838
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/srep24838</ArticleId>
            <ArticleId IdType="pmc">PMC4837405</ArticleId>
            <ArticleId IdType="pubmed">27094081</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Biagioli M, Carino A, Cipriani S, Francisci D, Marchiano S, Scarpelli P, et al. . The Bile Acid Receptor GPBAR1 Regulates the M1/M2 Phenotype of Intestinal Macrophages and Activation of GPBAR1 Rescues Mice from Murine Colitis. J Immunol (2017) 199:718–33.  10.4049/jimmunol.1700183
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.1700183</ArticleId>
            <ArticleId IdType="pubmed">28607110</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Vavassori P, Mencarelli A, Renga B, Distrutti E, Fiorucci S. The bile acid receptor FXR is a modulator of intestinal innate immunity. J Immunol (2009) 183:6251–61.  10.4049/jimmunol.0803978
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.0803978</ArticleId>
            <ArticleId IdType="pubmed">19864602</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, deRoos P, et al. . Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature (2013) 504:451–5.  10.1038/nature12726
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature12726</ArticleId>
            <ArticleId IdType="pmc">PMC3869884</ArticleId>
            <ArticleId IdType="pubmed">24226773</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
